BioSpace News Archive

American Aires Inc. (CSE: WIFI) (OTC Pink: AAIRD) (“Aires” or the “Company”), a pioneer in EMF modulation technology, is pleased to announce that the Company has granted 10,000 stock options (each an “Option”) to an arm’s length consultant pursuant to option agreement and the terms and conditions of the omnibus long-term incentive plan of the Company.

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the “Company” or “Sona”) is pleased to announce that it has closed its private placement that was announced on October 18, 2023 with the issuance of 3,750,000 shares at $0.20 per share and 1,875,000 common share purchase warrants

Kronos Bio, Inc. (Nasdaq: KRON) today announced that Norbert Bischofberger, Ph.D., president and chief executive officer, Jorge DiMartino M.D., Ph.D., chief medical officer and executive vice president of clinical development, and Charles Lin, Ph.D., senior vice president of TRN Mapping will participate in a fireside chat at the 35th Annual Piper Sandler Healthcare Conference on Tuesday, November 28, 2023 at 4:00 p.m. ET.

Priothera Ltd. announced that the US Food and Drug Administration has granted Orphan Drug designation to mocravimod for the ‘treatment to improve outcome following hematopoietic stem cell transplantation in hematologic malignancies’.

Seneca Therapeutics, Inc., announced today Dr. Paul Hallenbeck will present a talk titled “ Facilitating multiple deliveries of therapeutic viruses by exploiting natural methods of evading neutralizing immunity ”, during the World Vaccine Congress in Santa Clara, CA on November 28, 2023.

An exclusive initiative by the Israeli biotechnology company Amorphical brings a breakthrough approach to treating a variety of chronic inflammatory and oncological diseases.

Kraig Biocraft Laboratories, Inc., the biotechnology company focused on the development and commercialization of spider silk, announced its continued investment into building its world-class team with the addition of leading sericulture consultants from India.

Xenon Pharmaceuticals Inc. today reported topline results from the randomized, double-blind, placebo-controlled, Phase 2 proof-of-concept X-NOVA clinical trial, which evaluated the clinical efficacy, safety, and tolerability of 10 mg and 20 mg of XEN1101 in 168 patients with moderate to severe major depressive disorder, or MDD.

Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth , President and Chief Executive Officer, and Kim Kelderman , Chief Operating Officer will present at the 6th Annual Evercore ISI HealthCONx Conference on Wednesday, November 29, 2023, at 2:10 p.m. EST.

RTI Surgical, a leading global medical device organization, announced that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval for a clinical study designed to confirm the safety and effectiveness of Cortiva ® Allograft Dermis in implant-based breast reconstruction.